REZUROCK is undoubtedly an inhibitor of UGT1A1. Coadministration of REZUROCK using a UGT1A1 substrate diminished plasma concentrations with the glucuronide metabolite, which can enhance the hazard of adverse reactions connected with delicate substrates of UGT1A1An engineering method of Specific genes encoding designer receptors in cells as a way in